Drug Topics

SEPTEMBER 16, 2024

Patients who completed electronic patient-reported outcome measures said they made them feel more involved in their care and better supported.

154

154

STAT

SEPTEMBER 16, 2024

To address soaring rates of childhood obesity, the American Academy of Pediatrics last year endorsed tactics it once considered risky.  “Watchful waiting” had been standard practice, in part from concern that a doctor’s focus on weight could inadvertently plant the seed for stigma or eating disorders like anorexia and bulimia.

144

144

Fierce Healthcare

SEPTEMBER 16, 2024

Health plans are set to rake in $11.8 billion in Medicare Advantage quality bonus payments, according to a new analysis from KFF.

Insurance 132

Insurance 132

STAT

SEPTEMBER 16, 2024

In 2022, more than 22 million Americans had serious thoughts of suicide or had made a plan to end their life. To treat depression, the leading cause of suicide death, there is an urgent need for novel antidepressants, as existing ones are only effective roughly 50% of the time. But there is a serious problem with the way we conduct research to improve depression treatment.

142

142

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

SEPTEMBER 16, 2024

Data from the second interim analysis of the DETECT V trial, presented at ESMO Congress 2024, suggest that a chemotherapy-free regimen combining dual HER2-targeted therapy with endocrine therapy, particularly with the addition of ribociclib, may be an effective treatment for patients.

Chemotherapy 132

Chemotherapy 132

STAT

SEPTEMBER 16, 2024

In early August, a doctor was raped and murdered in a Kolkata public hospital by a “ civic volunteer ” who was neither a patient nor a staff member. The crime has enraged and rattled the medical profession in India. For weeks now, doctors have been protesting throughout the country, demanding among other things “justice for the victim” and a safer work environment.

Hospitals 142

Hospitals 142

STAT

SEPTEMBER 16, 2024

More work needs to be done by the agricultural sector to get to the bottom of — and put a stop to — transmission of H5N1 bird flu in dairy cattle in the United States, a senior World Health Organization official said over the weekend. Maria Van Kerkhove, the WHO’s acting director of epidemic and pandemic preparedness and prevention, said the world is watching how the U.S., with its advanced scientific expertise, is responding to this outbreak.

139

139

Fierce Healthcare

SEPTEMBER 16, 2024

The National Committee for Quality Assurance (NCQA) on Monday released its annual insurance rankings, with just five plans evaluated earning top marks. | The National Committee for Quality Assurance on Monday released its annual insurance rankings, with just five plans evaluated earning top marks.

Insurance 126

Insurance 126

STAT

SEPTEMBER 16, 2024

For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place where researchers have developed new therapies in-house and published high-impact papers. But the recent closure of a high-profile research group and multiple rounds of layoffs have many in the scientific community — including some of the company’s current and former employees — concerned about the biotech’s future and scientific strate

136

136

Fierce Healthcare

SEPTEMBER 16, 2024

A large portion of physicians say they are toying with plans to leave their current position in the near future—a tough issue for healthcare organizations keenly aware of a practitioner shortage pr | About 35% of doctors said they are likely to walk out the door within the next five years, with about 60% saying they’re likely to leave clinical practice wholesale, according to a recent McKinsey survey.

125

125

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

SEPTEMBER 16, 2024

BARCELONA, Spain — Ten years ago, a new type of cancer treatment reached the market. It worked by rousing the body’s own immune cells to attack tumors. Within months, regulators had approved two of the treatments, at first for melanoma.   The story — and the transformative impact — of Bristol Myers Squibb’s Opdivo and Merck’s Keytruda are well known at this point.

Immunization 134

Immunization 134

Fierce Healthcare

SEPTEMBER 16, 2024

Walgreens has agreed to a $106.8 million settlement over drug prescriptions that were billed to government programs but never dispensed, the Department of Justice announced Friday. | The government acknowledged Walgreens' cooperation in disclosing its improperly received payments and refunding $66 million, for which it received a credit toward the settlement amount.

124

124

STAT

SEPTEMBER 16, 2024

When someone’s heart doesn’t beat quite right, an implantable defibrillator can save their life. The devices can jump-start a misbehaving heart, resetting its normal rhythm — unless they malfunction first. In 2022, Medtronic recalled more than 85,000 of the devices after dozens of complaints that a technical glitch could stop them from delivering the right, high-voltage shock.

Documentation 124

Documentation FDA 124

Pharmaceutical Technology

SEPTEMBER 16, 2024

While Lykos Therapeutics’ MDMA therapy was rejected by the FDA, psychedelic therapy advocates remain optimistic about the sector.

FDA 119

FDA 119

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

SEPTEMBER 16, 2024

FDA raps AbbVie for 'misleading' ad for migraine drug Ubrelvy featuring tennis star Serena Williams

FDA 119

FDA 119

Drug Topics

SEPTEMBER 16, 2024

According to various research studies, these are the most commonly used interventions patients consider for treating and managing childhood obesity.

112

112

pharmaphorum

SEPTEMBER 16, 2024

Pfizer's anti-GDF-15 antibody ponsegromab was able to achieve weight gain in cancer patients with cachexia in a phase 2 trial presented at ESMO

114

114

Drug Topics

SEPTEMBER 16, 2024

Albert Dahan, MD, PhD, discusses recent data on Tris Pharma’s first-in-class dual-NMR agonist and how it will fit into the broader landscape of pain management therapies.

112

112

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

SEPTEMBER 16, 2024

Cigna is rolling out a new "E-Treatment" program for its members in partnership with its MDLIVE unit. | Cigna is rolling out a new "E-Treatment" program for its members in partnership with its MDLIVE unit.

111

111

pharmaphorum

SEPTEMBER 16, 2024

AstraZeneca reveals 'practice changing' data for Imfinzi as peri-operative therapy for bladder cancer, but will the FDA accept the study?

FDA 111

FDA 111

Pharmacy Times

SEPTEMBER 16, 2024

With the end of the PREP Act provisions approaching, we want to understand how pharmacists feel about their scopes of practice in each state, and what they think about the future of the profession.

107

107

pharmaphorum

SEPTEMBER 16, 2024

Changing Faces: Discover the latest board of directors appointments for Arctoris, BioConnection, Neurocare Group, PureTech Health and more in August 2024. Stay informed and up-to-date with these industry leaders.

108

108

Fierce Healthcare

SEPTEMBER 16, 2024

Combating healthcare burnout while enhancing patient care cbroadwell Mon, 09/16/2024 - 12:49

Patient Care 106

Patient Care 106

Fierce Pharma

SEPTEMBER 16, 2024

Following a meeting with the FDA’s Gastrointestinal Drug Advisory Committee Friday, the future of Intercept’s rare liver disease drug Ocaliva is under serious threat. | Looking to assess whether Ocaliva met its postmarketing requirements after a 2016 accelerated approval in the autoimmune disease primary biliary cholangitis, an FDA council of outside experts nearly unanimously rejected Intercept’s hopes for a full approval.

FDA 105

FDA 105

pharmaphorum

SEPTEMBER 16, 2024

Rates of cancer among people aged 24 and below are rising fast, but health systems are often not catering well enough to the specific needs of this age group.A new partnership has been set up between the Ella Dawson Foundation, a UK-based charity for young people with cancer, and digital cancer care company Careology to try to tackle that deficit and improve their treatment and wellbeing.

105

105

The Guardian - Pharmaceutical Industry

SEPTEMBER 16, 2024

World leaders will meet in New York this month to discuss growing antimicrobial resistance as researchers warn the development of replacement drugs is stalling Superbugs ‘could kill 39m people by 2050’ amid rising drug resistance Almost a century on from the groundbreaking discovery of penicillin by Alexander Fleming, his scientific successors are racing to save modern medicine.

103

103

Fierce Pharma

SEPTEMBER 16, 2024

The same set of clinical data on Cabometyx and Tecentriq in prostate cancer has led to two distinct regulatory plans between Exelixis and its partner Ipsen. | The same set of clinical data on Cabometyx and Tecentriq in prostate cancer has led to two distinct regulatory plans between Exelixis and its partner Ipsen.

FDA 101

FDA 101

Pharmacy Times

SEPTEMBER 16, 2024

The non-opioid drug can induce healing of joint cartilage in patients with osteoarthritis.

FDA 101

FDA 101

STAT

SEPTEMBER 16, 2024

Good morning, everyone, and welcome to another working week. We hope the weekend respite was invigorating and refreshing, because that oh-so familiar routine of online meetings, phone calls, and deadlines has returned. But you knew this would happen, yes? After all, the world, such as it is, continues to spin. So time to give it a nudge in a better direction with a cup or three of stimulation.

Chemotherapy 99

Chemotherapy 99

Pharmacy Times

SEPTEMBER 16, 2024

There is a need for continued research and awareness in the diagnosis and management of alopecia in diverse populations.

101

101

Pharmaceutical Technology

SEPTEMBER 16, 2024

The Phase III trial evaluating nerandomilast as a treatment for idiopathic pulmonary fibrosis met its primary endpoint.

98

98

Fierce Pharma

SEPTEMBER 16, 2024

Three years after establishing an immunology unit, Eli Lilly has gained its third FDA approval in the specialty area as the U.S. | Three years after establishing an immunology unit, Eli Lilly has gained its third FDA approval in the specialty area as the U.S. regulator has signed off on IL-13 inhibitor Ebglyss, or lebrikizumab, to treat atopic dermatitis.

FDA 98

FDA 98

Pharmaceutical Technology

SEPTEMBER 16, 2024

Roche has secured approval from the US Food and Drug Administration for Ocrevus Zunovo with Halozyme's Enhanze drug delivery technology.

FDA 98

FDA 98